HMGB1, released by dying tumor cells, may be recognized by DCs in a Toll-like receptor 4 (TLR4)- and myeloid differentiation primary response gene 88 (MyD88)-dependent manner, leading to a potent immune response (Figure 1a). Here, TLR4 is linked to neoplasm.